Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Infection and Immunity
|
July 23, 2003
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens
N Ariel, A Zvi, K S Makarova, et al.
Journal of Virology
|
February 1, 1992
Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity
H Grosfeld, S Lustig, Y Gozes, et al.
Journal of Interferon Research
|
April 1, 1989
Production of monoclonal antibodies toward bovine interferons-alpha suitable for immunopurification
D Kobiler, H Grosfeld, M Leitner, et al.
The Journal of Biological Chemistry
|
August 15, 1993
Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket
A Ordentlich, D Barak, C Kronman, et al.
Gene
|
November 16, 1992
Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit
C Kronman, B Velan, Y Gozes, et al.
Archives of Virology
|
January 1, 1990
Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus
N Ariel, S Lehrer, E Elhanaty, et al.
FEBS Letters
|
May 5, 1997
Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometry
R Barak, A Ordentlich, D Barak, et al.
Cellular and Molecular Neurobiology
|
February 1, 1991
Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme
B Velan, C Kronman, H Grosfeld, et al.
Vaccine
|
July 26, 2005
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components
I Mendelson, O Gat, R Aloni-Grinstein, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1996
Alphavirus hybrid virion vaccines
A Shafferman, S Lustig, Y Inbar, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Infection and Immunity
|
July 23, 2003
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens
N Ariel, A Zvi, K S Makarova, et al.
Journal of Virology
|
February 1, 1992
Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity
H Grosfeld, S Lustig, Y Gozes, et al.
Journal of Interferon Research
|
April 1, 1989
Production of monoclonal antibodies toward bovine interferons-alpha suitable for immunopurification
D Kobiler, H Grosfeld, M Leitner, et al.
The Journal of Biological Chemistry
|
August 15, 1993
Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket
A Ordentlich, D Barak, C Kronman, et al.
Gene
|
November 16, 1992
Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit
C Kronman, B Velan, Y Gozes, et al.
Archives of Virology
|
January 1, 1990
Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus
N Ariel, S Lehrer, E Elhanaty, et al.
FEBS Letters
|
May 5, 1997
Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometry
R Barak, A Ordentlich, D Barak, et al.
Cellular and Molecular Neurobiology
|
February 1, 1991
Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme
B Velan, C Kronman, H Grosfeld, et al.
Vaccine
|
July 26, 2005
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components
I Mendelson, O Gat, R Aloni-Grinstein, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1996
Alphavirus hybrid virion vaccines
A Shafferman, S Lustig, Y Inbar, et al.
Page
of 7